Lamivudine for chronic hepatitis B and HIV co-infection

AIDS. 1999 May 28;13(8):1002-3. doi: 10.1097/00002030-199905280-00024.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • DNA, Viral / analysis
  • HIV / drug effects
  • HIV / genetics
  • HIV / physiology
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / genetics
  • Hepatitis B virus / physiology
  • Hepatitis B, Chronic / complications
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Lamivudine / therapeutic use*
  • Male
  • Middle Aged
  • RNA, Viral / blood
  • Reverse Transcriptase Inhibitors / therapeutic use

Substances

  • Anti-HIV Agents
  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B e Antigens
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Lamivudine